Statistics
Publications
5
Citations
399
H-Index
5
Active since
2000
Affiliations
Ricardo Alvarado-Ruiz is an author at Durango Institute of Technology specializing in cardiovascular disease, cardiology, and coronary artery disease.
Publications per year
2000–2021
5
5
Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy
Vivian Fonseca, Ricardo Alvarado-Ruiz, D. Raccah et al. · Diabetes Care · 2012 · 218 citations · Full text
1–5 of 5